Diagnosis

• Patient: Mrs. Kanaklata Das, 50-year-old female
• Specimen: Urine (midstream, likely)
• Colony count: ~10^4 CFU/ml (significant, especially with symptoms)
• Organism: Proteus species (likely P. mirabilis)
• Clinical significance: Proteus spp. are common uropathogens, particularly in women. They produce urease, which splits urea into ammonia, raises urinary pH, and can lead to struvite (infection) stone formation if untreated.

Antibiogram Summary

Note: Resistance to carbapenems (Imipenem, Meropenem) is clinically significant but does not compromise treatment here since multiple oral and parenteral alternatives remain active.

Treatment Recommendations

For Uncomplicated UTI (cystitis only, no fever/flank pain):

1. Ciprofloxacin 500 mg twice daily for 5-7 days - Sensitive ++, excellent oral bioavailability, best for Proteus
2. Cefuroxime 500 mg twice daily for 7 days - Sensitive ++, safe oral option
3. TMP-SMX (Trimethoprim-Sulfamethoxazole) 960 mg twice daily for 5-7 days - Sensitive ++, cost-effective
4. Cefixime 200-400 mg once/twice daily for 7 days - Sensitive ++, well tolerated

For Pyelonephritis (upper UTI with fever, flank pain, rigors):

1. Ceftriaxone 1g IV/IM once daily (initial dose or 2-3 days) then switch to oral ciprofloxacin or cefuroxime to complete 10-14 days total
2. Ciprofloxacin 500 mg orally twice daily for 10-14 days (if symptoms are mild-moderate)
3. If hospitalized: Piperacillin/Tazobactam 4.5g IV every 8 hours or Amikacin 15 mg/kg/day IV (most potent options per sensitivity +++/++)

Important Clinical Points

1. Nitrofurantoin shows only Sensitive+ - Use only if cystitis is confirmed (lower UTI). It achieves poor tissue levels and should NOT be used for pyelonephritis or bacteremia.
2. Struvite stone risk - Proteus urease produces ammonia, alkalinizes urine, and can cause kidney stone formation. If this is a recurrent or complicated UTI, a renal ultrasound or plain X-ray (KUB) is recommended to rule out calculi.
3. Duration matters: Incomplete treatment of Proteus UTI in women may lead to recurrence or ascending infection. Complete the full antibiotic course.
4. Carbapenem resistance (Imipenem + Meropenem both resistant) is unusual but does not affect outpatient management since the organism remains sensitive to cephalosporins and fluoroquinolones.
5. Follow-up urine culture 5-7 days after completing treatment is advisable, especially given the resistant pattern to some drugs.

Practical First Choice (Outpatient)

Ciprofloxacin 500 mg orally twice daily for 7 days - best balance of sensitivity, oral availability, and Proteus coverage.

If cystitis only (no systemic features): TMP-SMX 960 mg (DS) twice daily for 5 days is a cost-effective alternative.